CompanyDeals

Alphamab Oncology Strikes Licensing Deal with CSPC Pharma for HER2 Targeted ADC in China

CompanyDrug

Sichuan Biokin’s Partner Bristol-Myers Squibb Gets FDA Nod for Bispecific ADC Study

CompanyDrug

J&J’s Carvykti Shows 45% Reduced Risk of Death in Multiple Myeloma Patients, Landmark Trial Data Reveals

CompanyDrug

Yabao Pharmaceutical’s SY-009 Receives NMPA Approval for Phase II Clinical Trial in Constipation

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Gets NMPA Green Light for Clinical Trial of TSLP-Targeted Asthma Treatment

CompanyR&D

Bayer AG Launches New Life Sciences Incubator in Shanghai to Boost Biotech Ecosystem

CompanyDrug

Huadong Medicine Gets NMPA Green Light for Clinical Trials of Roflumilast Cream

CompanyMedical Device

LenoMed Medical’s Touch-Insulin Pump Receives NMPA Approval, Aids China’s Diabetes Management

CompanyDeals

Mindray Bio-Medical Partners with Nanjing Drum Tower Hospital to Boost Clinical Research

CompanyDrug

Qilu Pharmaceutical’s QL1706 Receives NMPA Conditional Approval for Cervical Cancer Treatment

Policy / Regulatory

Study Predicts 2025 Medicare Part D Negotiation Candidates, With Novo Nordisk’s Semaglutide Leading the List

CompanyDrug

Dupixent Secures Back-to-Back COPD Approvals from US FDA and China NMPA